Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study

Autor: Loche S, Kanumakala S, Backeljauw P, Schwab KO, Lechuga-Sancho AM, Esmael A, Urosevic D, Boldea A, Zabransky M

Publikováno v: Drug Design, Development and Therapy, Vol Volume 18, Pp 667-684 (2024)

Sandro Loche,1 Shankar Kanumakala,2 Philippe Backeljauw,3 Karl Otfried Schwab,4 Alfonso M Lechuga-Sancho,5– 7 Altaher Esmael,8 Dragan Urosevic,9 Anca Boldea,8 Markus Zabransky8 1Endocrinologia Pediatra e Centro, Screening Neonatale, Ospedale Pediat

Externí odkaz: https://doaj.org/article/c01cf98fe8304b9ab906d8191ee82a05

Prader-Willi syndrome: guidance for children and transition into adulthood.

Autor: Shaikh MG; Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK.; Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK., Barrett TG; Department of Endocrinology, Birmingham Womens and Children's Hospital, Birmingham, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Bridges N; Department of Paediatric Endocrinology, Chelsea and Westminster Hospital, London, UK., Chung R; Research Working Group, Prader-Willi Syndrome Association, Northampton, UK., Gevers EF; Department of Paediatric Endocrinology, Barts Health NHS Trust, Royal London Hospital, London, UK.; Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK., Goldstone AP; PsychoNeuroEndocrinologyResearch Group, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK.; Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Holland A; Department of Psychiatry, University of Cambridge, Cambridge, UK., Kanumakala S; Royal Alexandra Children's Hospital, Brighton, UK., Krone R; Department of Endocrinology, Birmingham Womens and Children's Hospital, Birmingham, UK., Kyriakou A; Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK.; Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus., Livesey EA; Royal Alexandra Children's Hospital, Brighton, UK.; Sussex Community NHS Trust, Brighton, UK., Lucas-Herald AK; Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK.; Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK., Meade C; CHI at Tallaght University Hospital, Dublin, Republic of Ireland., Passmore S; Prader-Willi Syndrome Association, Northampton, UK., Roche E; CHI at Tallaght University Hospital, Dublin, Republic of Ireland.; The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland., Smith C; Royal Alexandra Children's Hospital, Brighton, UK., Soni S; Learning Disability Psychiatry, NHS Greater Glasgow and Clyde, Glasgow, UK.

Publikováno v: Endocrine connections [Endocr Connect] 2024 Jul 10; Vol. 13 (8). Date of Electronic Publication: 2024 Jul 10 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and effectiveness of Omnitrope ^® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data.

Autor: Backeljauw P; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Kanumakala S; Royal Alexandra Children's Hospital, University Hospitals Sussex NHS Trust, Brighton, UK., Loche S; Ospedale Pediatrico Microcitemico 'A. Cao', AO Brotzu, Cagliari, Italy., Schwab KO; Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Miller BS; University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA., Levy R; Rush University Medical Center, Chicago, IL, USA., McCormick K; Division of Endocrinology, University of Alabama at Birmingham, Birmingham, AL, USA., Zouater H; Sandoz Biopharmaceuticals, c/o HEXAL AG, Holzkirchen, Germany., Zabransky M; Sandoz Biopharmaceuticals, c/o HEXAL AG, Holzkirchen, Germany., Campbell K; Sandoz Inc, Princeton, NJ, USA. kim.campbell@sandoz.com.

Publikováno v: European journal of pediatrics [Eur J Pediatr] 2022 Jun; Vol. 181 (6), pp. 2367-2378. Date of Electronic Publication: 2022 Mar 11.

Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.

Autor: Backeljauw P; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Kanumakala S; Royal Alexandra Children's Hospital, Brighton, United Kingdom., Loche S; Hospital for Children Microcitemico 'A. Cao', Cagliari, Italy., Schwab KO; Department of Pediatrics, University Medical Center, Freiburg, Germany., Pfäffle RW; Department of Pediatrics, University of Leipzig, Leipzig, Germany., Höybye C; Department of Endocrinology, Karolinska University Hospital, Solna, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Lundberg E; Institute of Clinical Science/Pediatrics, Umeå University, Umeå, Sweden., Battelino T; Department of Paediatric Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre-University Children's Hospital, and University of Ljubljana, Ljubljana, Slovenia., Kriström B; Institute of Clinical Science/Pediatrics, Umeå University, Umeå, Sweden., Giemza T; Sandoz Poland, Warsaw, Poland., Zouater H; Sandoz GmbH, Holzkirchen, Germany.

Publikováno v: Hormone research in paediatrics [Horm Res Paediatr] 2021; Vol. 94 (3-4), pp. 133-143. Date of Electronic Publication: 2021 Jul 07.